Moore Capital Management LP Sells 38,495 Shares of Sotera Health Company $SHC

Moore Capital Management LP trimmed its position in shares of Sotera Health Company (NASDAQ:SHC) by 15.2% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 213,946 shares of the company’s stock after selling 38,495 shares during the quarter. Moore Capital Management LP owned 0.07% of Sotera Health worth $3,798,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of the business. PNC Financial Services Group Inc. boosted its stake in shares of Sotera Health by 10.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company’s stock valued at $127,000 after purchasing an additional 705 shares during the period. Strs Ohio increased its holdings in Sotera Health by 17.4% during the fourth quarter. Strs Ohio now owns 4,895 shares of the company’s stock valued at $86,000 after buying an additional 727 shares during the period. Federated Hermes Inc. grew its stake in Sotera Health by 6.0% in the fourth quarter. Federated Hermes Inc. now owns 16,676 shares of the company’s stock valued at $294,000 after purchasing an additional 944 shares during the last quarter. First Citizens Bank & Trust Co. increased its position in shares of Sotera Health by 1.5% during the fourth quarter. First Citizens Bank & Trust Co. now owns 66,266 shares of the company’s stock worth $1,169,000 after purchasing an additional 970 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its stake in Sotera Health by 1.7% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 64,993 shares of the company’s stock valued at $1,146,000 after buying an additional 1,061 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Down 1.9%

Shares of SHC opened at $18.90 on Tuesday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. Sotera Health Company has a one year low of $13.09 and a one year high of $19.85. The stock has a market capitalization of $5.39 billion, a price-to-earnings ratio of 33.16 and a beta of 1.77. The stock has a 50 day moving average price of $18.18 and a 200 day moving average price of $16.41.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. During the same quarter last year, the firm posted $0.20 EPS. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Equities research analysts forecast that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on SHC shares. Piper Sandler reiterated an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of Sotera Health in a research note on Friday, August 7th. Barclays increased their price target on shares of Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. The Goldman Sachs Group began coverage on Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective on the stock. Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Finally, JPMorgan Chase & Co. boosted their price target on shares of Sotera Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $21.50.

Insider Activity

In other news, insider Michael P. Rutz sold 150,000 shares of the firm’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the transaction, the insider directly owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares in the company, valued at $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 1,294,515 shares of company stock worth $23,999,528. Insiders own 15.36% of the company’s stock.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.